Can a simple risk calculator help catch prostate cancer earlier in nigerian men?
NCT ID NCT07733440
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This pilot trial tests whether a risk calculator designed for Nigerian men can help primary care providers better identify those with clinically significant prostate cancer. Researchers will train healthcare workers at community hospitals and then support them in using the tool for at least six months. The main goal is to see if the calculator is feasible and acceptable in everyday practice, not yet to measure its impact on cancer outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Training and supported risk assessment using a prostate cancer risk calculator
- What this could lead to
- If successful, this approach could improve early detection of prostate cancer in Nigerian men, potentially saving lives through earlier treatment.
- What could go wrong
- This is a small pilot study focused on feasibility, not on directly measuring cancer outcomes. The risk calculator may not work as well in real-world settings or may not be adopted by providers.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AFRICA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ahmadu Bello University Teaching Hospital
Zaria, Kaduna State, Nigeria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI vs. Doctor's intuition: which leads to better diagnoses?
- AI coaches doctors on cancer risk talks